| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.07 |